Clarity on Endpoints for Clinical Trials in Idiopathic Pulmonary Fibrosis

Ann Am Thorac Soc. 2017 Sep;14(9):1383-1384. doi: 10.1513/AnnalsATS.201706-423ED.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Humans
  • Idiopathic Pulmonary Fibrosis*
  • Respiratory System Agents*
  • Tidal Volume
  • Vital Capacity

Substances

  • Respiratory System Agents